Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2335330rdf:typepubmed:Citationlld:pubmed
pubmed-article:2335330lifeskim:mentionsumls-concept:C0005768lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0011065lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0032780lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0002792lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0019588lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0086272lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:2335330lifeskim:mentionsumls-concept:C0205198lld:lifeskim
pubmed-article:2335330pubmed:issue1-2lld:pubmed
pubmed-article:2335330pubmed:dateCreated1990-6-13lld:pubmed
pubmed-article:2335330pubmed:abstractTextThe present study was made on an experimental animal model of a death from anaphylaxis, in which postmortem changes in levels of histamine and 1-methylhistamine, in whole blood were measured. Instead of the usual immunological method administering compound 48/80, a degranulating agent of mast cell and the effect closely resembling the immuno-reaction, resulted in reliable death in a short time. The animals that died rapidly after the injection of compound 48/80, were found to have large increases in levels of histamine and 1-methylhistamine soon after the administration. These results were similar to the results of injecting histamine exogenously. On the other hand, the animals that died after a longer time showed no increases in levels of those amines within about 24 h, but 24 hours after death histamine levels were only increased tremendously without rise in 1-MHA levels. These phenomena closely resembled those in the control animals that were treated with overdoses of Nembutal.lld:pubmed
pubmed-article:2335330pubmed:languageenglld:pubmed
pubmed-article:2335330pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2335330pubmed:citationSubsetIMlld:pubmed
pubmed-article:2335330pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2335330pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2335330pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2335330pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2335330pubmed:statusMEDLINElld:pubmed
pubmed-article:2335330pubmed:monthMarlld:pubmed
pubmed-article:2335330pubmed:issn0379-0738lld:pubmed
pubmed-article:2335330pubmed:authorpubmed-author:HaraKKlld:pubmed
pubmed-article:2335330pubmed:authorpubmed-author:TakamotoMMlld:pubmed
pubmed-article:2335330pubmed:authorpubmed-author:KashimuraSSlld:pubmed
pubmed-article:2335330pubmed:authorpubmed-author:HiedaYYlld:pubmed
pubmed-article:2335330pubmed:authorpubmed-author:KageuraMMlld:pubmed
pubmed-article:2335330pubmed:authorpubmed-author:FukumaYYlld:pubmed
pubmed-article:2335330pubmed:issnTypePrintlld:pubmed
pubmed-article:2335330pubmed:volume45lld:pubmed
pubmed-article:2335330pubmed:ownerNLMlld:pubmed
pubmed-article:2335330pubmed:authorsCompleteYlld:pubmed
pubmed-article:2335330pubmed:pagination159-69lld:pubmed
pubmed-article:2335330pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:meshHeadingpubmed-meshheading:2335330-...lld:pubmed
pubmed-article:2335330pubmed:year1990lld:pubmed
pubmed-article:2335330pubmed:articleTitleAn experimental model of death from anaphylactic shock with compound 48/80 and postmortem changes in levels of histamine in blood.lld:pubmed
pubmed-article:2335330pubmed:affiliationDepartment of Legal Medicine, Fukuoka University School of Medicine, Japan.lld:pubmed
pubmed-article:2335330pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2335330pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2335330pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed